Evidence map›Paper›PMID 27900064›Full record

ArticleJournal of dermatological case reports2016

Enzalutamide induced acute generalized exanthematous pustulosis.

Chloé Alberto, Maria Polina Konstantinou, Catherine Martinage, Eline Casassa, Emilie Tournier, Haleh Bagheri, Vincent Sibaud, Loïc Mourey, Juliette Mazereeuw-Hautier, Nicolas Meyer and 2 more

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of dermatological case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Chloé AlbertoPaul Sabatier University, Department of Dermatology, Larrey Hospital and Institut Universitaire du Cancer, Toulouse, France.
Maria Polina KonstantinouPaul Sabatier University, Department of Dermatology, Larrey Hospital and Institut Universitaire du Cancer, Toulouse, France.
Catherine MartinagePaul Sabatier University, Department of Dermatology, Larrey Hospital and Institut Universitaire du Cancer, Toulouse, France.
Eline CasassaPaul Sabatier University, Department of Dermatology, Larrey Hospital and Institut Universitaire du Cancer, Toulouse, France.
Emilie TournierDepartment of Pathology, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
Haleh BagheriDepartment of Medical and Clinical Pharmacology, Toulouse University Hospital, Toulouse, France.
Vincent SibaudPaul Sabatier University, Department of Dermatology, Larrey Hospital and Institut Universitaire du Cancer, Toulouse, France.
Loïc MoureyDepartment of Oncology, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
Juliette Mazereeuw-HautierPaul Sabatier University, Department of Dermatology, Larrey Hospital and Institut Universitaire du Cancer, Toulouse, France.
Nicolas MeyerPaul Sabatier University, Department of Dermatology, Larrey Hospital and Institut Universitaire du Cancer, Toulouse, France.
Carle PaulPaul Sabatier University, Department of Dermatology, Larrey Hospital and Institut Universitaire du Cancer, Toulouse, France.
Cristina Bulai LivideanuPaul Sabatier University, Department of Dermatology, Larrey Hospital and Institut Universitaire du Cancer, Toulouse, France.
Hôpital Larrey · FRUniversité Toulouse III - Paul Sabatier · FRInstitut universitaire du cancer de Toulouse Oncopole · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction

objectiveWe report the first case of acute generalized exanthematous pustulosis (AGEP) induced by OBSERVATION: A 62-year-old male patient with no significant medical history, was diagnosed in April 2014 with metastatic prostatic adenocarcinoma. In April 2015 the patient received a second line oral therapy with

conclusionsDermatologist can be confronted with adverse skin drug reactions attributable to new therapeutic molecules. The slow resolution of symptoms seems be due to the long half-life of

Indexed as

acute generalized exanthematous pustulosisdrug eruptionenzalutamidepustular skin eruptionXtandi®

Identifiers

PMID27900064
PMCPMC5124370
OpenAlexW2550545590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.